发明名称
摘要 Pharmaceutically active aluminium compounds are obtained by reacting aluminium alkoxides with at least one pharmacologically active substance containing at least one hydroxyl carboxylic acid, phenolic, imido or keto-enolic group and with at least one substance containing a hydrolysis-limiting group selected from oleic acid, stearic acid, oleyl alcohol, stearyl alcohol, ceto stearyl alcohol, castor oil and benzoic acid, so as to obtain a monomeric reaction product. As pharmacologically active substances there may be used tribromoethanol, trichloro-t-but</>anol, methyl pentynol, chloral hydrate, benzyl alcohol, 3-(2-methylphenoxy) - propane - 1,2 - diol, glycerol, ethanolamine, salicylic acid and its esters, acetyl salicylic acid, p-amino-salicylic acid, barbituric acid, saccharin, ascorbic acid, gluconic acid, glucose, sorbitol, sucrose, maltose, raffinose, lactose, testosterone, androsterone, hexoestral, triphenylchlorethylene, progesterone, prednisolone, ephedrine, adrenaline, penicillin, aureomycin, chloramphenicol, tetracycline hydrochloride, oxytetracycline hydrochloride, erythromycin, thymol, hexyl resorcinol, phenophthalein, aloe-emodin, stilboestrol, bis-hydroxy coumarin, mandelic acid, benzoic acid, lactic acid, chaulmoogric acid, nicotinic acid, nicotinamide, phenacetin or acetanilide.
申请公布号 SE309045(B) 申请公布日期 1969.03.10
申请号 SE19600008503 申请日期 1960.09.06
申请人 HARDMAN & HOLDEN LTD 发明人 DAVISON B
分类号 C07F5/06;(IPC1-7):C07F5/06 主分类号 C07F5/06
代理机构 代理人
主权项
地址